DailyDoctor Archive Specialties Get app
All orthopaedics briefings

The edition · Orthopaedics

About one in ten patients with spinal metastases lives five years — plan the operation for them too

A 926-patient registry puts a long-term number on spinal metastatic disease, a JBJS review makes periprosthetic fracture prevention part of every hip replacement, and joint replacement under 25 works but carries more revisions.

The edition in brief

A Boston registry of 926 patients treated with or without surgery for spinal metastases between 2017 and 2025 found a five-year survival of 8.9% (95% CI 7.2% to 10.9%), lowest in lung cancer. Both the SORG nomogram and the New England Spinal Metastasis Score predicted survival up to five years. About one patient in ten will outlive the usual assumptions, so scores should guide both the decision to operate and the durability of the construct. A JBJS review warns that periprosthetic femoral fractures after hip replacement are rising, with mortality comparable to hip fragility fractures, and argues that prevention — bone health, implant choice and fall prevention — belongs in routine arthroplasty care. A meta-analysis of 44 studies of hip and knee replacement in patients under 25 found large functional gains but all-cause revision of 8.7% after hip and 12.4% after knee replacement, improving in more recent cohorts. A UK register study of 182 secondary patellar resurfacings found meaningful gains in Oxford Knee Score and about 80–86% satisfaction, best when done more than 2.5 years after the primary knee.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for orthopaedics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free